Alignment Healthcare president sells over $49,000 in company stock By

Alignment Healthcare, Inc. (NASDAQ:ALHC) President of Markets, Dawn Christine Maroney, recently sold 10,151 shares of the company’s stock, worth approximately $49,130. The transaction took place on March 28, 2024, with share prices ranging from $4.73 to $4.935.

The sale was made in order to pay off tax liabilities related to the issuance of restricted shares. This was not a discretionary sale, indicating that the shares were sold as a formality in accordance with the compensation agreement rather than as a business decision.

Following the sale, Maroney retains direct ownership of 1,976,097 shares in the company. Actual transactions were reported at a weighted average price of $4.84 per share. This is of great value to potential and potential investors as it highlights the latest business developments within Alignment Healthcare, providing information on key activities and trends within the company.

Investors and stakeholders of Alignment Healthcare may request information on the number of shares traded at any given price, if required. This transparency is part of the company’s commitment to maintaining open communication channels with shareholders.

The disclosures were made in accordance with the Securities and Exchange Commission’s requirements, which require that company insiders make timely disclosures of such transactions.

InvestingPro Insights

As Alignment Healthcare, Inc. (NASDAQ:ALHC) moves through its financial landscape, other metrics and analysts from InvestingPro can provide a deeper understanding of the company’s valuation and market trends. According to InvestingPro data, Alignment Healthcare has a market capitalization of $937.33 million and is trading at a high Price / Book multiple of 5.97 as of the last twelve months at the end of Q4 2023. book value, which may be interesting for investors who they have value.

Despite a strong revenue growth of 27.16% in the last twelve months as of Q4 2023, Alignment Healthcare has not been profitable during this period, with a reported operating income of -6.9%. The company’s P/E ratio stands at -6.39, indicating its lack of profitability in the past. This is confirmed by InvestingPro Tip, which indicates that analysts do not expect the company to be profitable this year.

Another InvestingPro guide shows that the stock has fallen significantly over the past three months, with a total return of -42.39%. This could attract investors looking for potential turnarounds or those looking to bet on recovery. For those considering a deeper analysis, there are additional InvestingPro Guides available at, which can inform investment decisions. To get this information, investors can use coupons PRONEWS24 to receive an additional 10% on annual or bi-annual Pro and Pro+ subscriptions.

Note that the company’s next earnings date is expected to be May 2, 2024, which may provide important information about the stock’s performance. There are 9 of them InvestingPro With the guidance available, investors have sufficient information to consider when evaluating the potential risks and opportunities associated with Alignment Healthcare.

This article was created with the help of AI and reviewed by an editor. For more information see our T&C.

!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=’2.0′;n.queue=[];t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,’script’,’’);

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *